Romidepsin

Basic Information

Item Value
DrugBank ID DB06176
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 dermatofibrosarcoma protuberans KG + DL
2 fibroblastic neoplasm KG + DL
3 kidney fibrosarcoma KG + DL
4 heart fibrosarcoma KG + DL
5 conventional fibrosarcoma KG + DL
6 familial rhabdoid tumor KG + DL
7 low grade fibromyxoid sarcoma KG + DL
8 liver fibrosarcoma KG + DL
9 liposarcoma KG + DL
10 uterine corpus perivascular epithelioid cell tumor KG + DL
11 benign PEComa KG + DL
12 lymphangiomyoma KG + DL
13 bone fibrosarcoma KG + DL
14 ovarian myxoid liposarcoma KG + DL
15 uterine corpus myxoid leiomyosarcoma KG + DL
16 lymphangioleiomyomatosis KG + DL
17 Plasmodium falciparum malaria KG + DL
18 uterine corpus epithelioid leiomyosarcoma KG + DL
19 vulva sarcoma KG + DL
20 anus leiomyosarcoma KG + DL
21 leiomyosarcoma KG + DL
22 retroperitoneal sarcoma KG + DL
23 small intestinal sarcoma KG + DL
24 cutaneous undifferentiated pleomorphic sarcoma KG + DL
25 autosomal recessive familial Mediterranean fever KG + DL
26 central nervous system fibrosarcoma KG + DL
27 gallbladder leiomyosarcoma KG + DL
28 lung PEComa KG + DL
29 cutaneous leiomyosarcoma (disease) KG + DL
30 breast fibrosarcoma KG + DL
31 mixed endometrial stromal and smooth muscle tumor KG + DL
32 HIV infectious disease KG + DL
33 aleukemic mast cell leukemia KG + DL
34 rete ovarii cystadenoma KG + DL
35 borderline ovarian serous tumor KG + DL
36 spindle cell liposarcoma KG + DL
37 ovarian papillary cystadenoma KG + DL
38 botryoid-type embryonal rhabdomyosarcoma of the vagina KG + DL
39 malignant ovarian Brenner tumor KG + DL
40 ovarian benign neoplasm KG + DL
41 mucinous ovarian cystadenoma KG + DL
42 simian immunodeficiency virus infection KG + DL
43 feline acquired immunodeficiency syndrome KG + DL
44 extrahepatic bile duct rhabdomyosarcoma KG + DL
45 parameningeal embryonal rhabdomyosarcoma KG + DL
46 ovarian mucinous cystadenofibroma KG + DL
47 prostate embryonal rhabdomyosarcoma KG + DL
48 collagenopathy KG + DL
49 ovarian surface papilloma KG + DL
50 embryonal extrahepatic bile duct rhabdomyosarcoma KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.